According to the new market research report "In
situ Hybridization Market by Technique (FISH, CISH), Application (Cancer Diagnosis,
Neuroscience, Cytology, Infectious Disease), & End User (Molecular
Diagnostic Laboratories, Academic And Research Institutions) - Global Forecast
to 2021", published by MarketsandMarkets™,
analyzes and studies the major
market drivers, restraints/challenges, and opportunities.
Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=212028829
The
in situ hybridization market is projected to reach USD 739.9 Million by 2021
from USD 557.1 Million in 2016, at a CAGR of 5.8% in the next five years (2016
to 2021).
In the coming years, the
market is expected to witness the highest growth in the Asia-Pacific region.
This can be attributed to the growing presence of international players in
China and India, increasing cancer prevalence and diagnosis, and increased
healthcare expenditure across the Asia-Pacific region are drivers for the in
situ hybridization market in this region.
North America is expected
to account for the largest share of the global market. This can be attributed
to growing clinical and research in cancer by biotechnology and pharmaceutical
companies, government initiatives, increasing prevalence and diagnosis of
cancer in the U.S. and Canada, and increasing adoption of companion
diagnostics. Increased adoption of companion diagnostics is attributed to the
development and launch of newer therapeutic agents.
Browse and
in-depth TOC on " In situ Hybridization Market "
View
more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/in-situ-hybridization-market-212028829.html
In the U.S., the in situ hybridization market is driven by
increasing government initiatives, growing biomedical research, rising
prevalence of cancer, and growing demand for companion diagnostics and
personalized medicine. In Canada, the growth of the market is driven by
increased government funding and growing prevalence of cancer.
The report segments market based on technique, application, end
user, and region.
On the basis of technique, the global market is segmented into
fluorescent in situ hybridization (FISH) and chromogenic in situ hybridization
(CISH). The FISH segment is expected to command the largest share of the global
in situ hybridization market, by technique in 2016. This segment is also
projected to grow at the highest CAGR during the forecast period (2016-2021).
This can be attributed to factors such as like high resolution of this
technique, rising adoption in research activities & laboratories to
diagnose cancer, chromosomal abnormalities, and infectious diseases, among
others.
Request
for Free Sample Report @
The in situ hybridization market is projected to reach
USD 739.9 Million by 2021 from USD 557.1 Million in 2016, at a CAGR of 5.8% in
the next five years (2016 to 2021). Increasing diagnosis and growing incidence
& prevalence of cancer, technology advancements in therapeutics, increasing
government initiatives globally are expected to drive the growth of the market
in the coming years.
The global market is segmented on the basis of technique,
application, and end user. By technique, the market is categorized into
fluorescent in situ hybridization (FISH) and chromogenic in situ hybridization
(CISH). The FISH segment is expected to command the largest share of the global
market, by technique in 2016. This segment is also projected to grow at the
highest CAGR during the forecast period (2016-2021). This can be attributed to
factors such as like high resolution of this technique, rising adoption in
research activities & laboratories to diagnose cancer, chromosomal
abnormalities, and infectious diseases, among others.
By application, the in situ hybridization market is categorized
into cancer diagnosis, cytology, neuroscience, immunology, and infectious
diseases. The cancer diagnosis segment is expected to command the largest share
of the global market, by application in 2016. This segment is also projected to
grow at the highest CAGR during the forecast period (2016-2021). This is
attributed to factors such as rising prevalence of cancer, increasing adoption
of FISH in diagnosis of cancer, and rising demand for FISH-based companion
diagnostics for cancer.
Browse
Adjacent Markets @ Biotechnology
Market Research Reports & Consulting
Comments
Post a Comment